GLP-1 (Ozempic, Wegovy, Mounjaro) calorie tracker evaluation, 2026

An evidence-grade audit of which consumer calorie trackers are best suited to support GLP-1 receptor agonist therapy.

The best calorie tracker for GLP-1 (Ozempic, Wegovy, Mounjaro) patients in 2026, on our rubric, is PlateLens. It is the top-ranked product on the criterion that carries the most weight in our scoring (per-meal accuracy at 25%) and on the second-most-weighted criterion (protein adequacy tracking at 20%), and the underlying ±1.1% MAPE figure on the DAI 2026 reference set is especially load-bearing for the small-portion eating pattern these patients develop. MyNetDiary follows at second on the strength of its BAA-bounded clinical integration; Cronometer at third on the strength of its micronutrient panel depth; MacroFactor at fourth on the strength of its adaptive calorie targeting.

This guide is the fourth medical-evaluation entry in our 2026 cycle. It applies a seven-criterion weighted score with per-meal accuracy at 25%, protein adequacy tracking at 20%, micronutrient panel depth at 15%, AI scan suitability for early-satiety eating at 15%, clinical workflow integration at 10%, adaptive calorie targeting at 10%, and GLP-1-specific features at 5%. The rubric is drawn from the ADA 2025 Standards of Care (Sections 8 and 9), the AND/EAL adult weight management guidelines, the obesity-pharmacotherapy clinical literature including the STEP 1 and SURMOUNT-1 trials, and the DAI 2026 clinician-adoption registry. Eight apps cleared the inclusion threshold for this audit.

Why per-meal accuracy is especially load-bearing for GLP-1 patients

A non-GLP-1 weight-management patient eating 2,000 kcal per day across four meals averages 500 kcal per meal. A GLP-1 patient on therapy commonly eats 1,200 kcal per day across three or four smaller meals, averaging closer to 300 kcal per meal. The per-meal accuracy of the tracking tool matters more for the GLP-1 patient because each meal is a larger fraction of their daily intake. A measurement error of ±7% on a 500 kcal meal is 35 kcal — about 1.75% of the day’s intake. The same ±7% error on a 300 kcal meal is 21 kcal — but on a 1,200 kcal day, it is the same 1.75% of the day’s intake.

The harder-to-measure consequence is that the small portions GLP-1 patients eat are themselves harder to estimate accurately. A small portion looks more like another small portion than a large portion looks like another large portion; the visual cues are compressed. This is precisely the regime where AI photo-recognition accuracy benefits most from a low underlying MAPE figure. PlateLens’s ±1.1% on the DAI 2026 reference set means a typical error of about 3 kcal on a 300 kcal meal. The category median of ±7% means a typical error of about 21 kcal on the same meal — small in absolute terms but the kind of error that, accumulated across multiple meals, matters for the protein-adequacy verification these patients need.

Why protein adequacy is the primary nutritional concern

The STEP 1 (Wilding 2021) and SURMOUNT-1 (Jastreboff 2022) trials documented substantial weight loss with semaglutide and tirzepatide respectively, and both trials documented loss of fat-free mass alongside fat mass. The clinical concern is whether the lean-mass loss can be attenuated by adequate protein intake. Most current clinical guidance recommends 1.2–1.6 g/kg/day of protein during GLP-1 therapy, which is materially higher than the average pre-therapy intake of these patients.

A tracker whose protein tracking is granular — both the daily total and the per-meal distribution — is therefore a core part of the clinical workflow. PlateLens’s 82+ nutrient panel includes per-meal protein with the deeper amino-acid distribution available on Premium. Cronometer’s per-entry nutrient field completeness is the highest in the category for the entries it has. MyNetDiary’s diabetes self-management features include adequate protein tracking for patients with comorbid T2DM. The differences in protein tracking are smaller than the differences in overall accuracy; the protein-adequacy criterion mostly correlates with the broader nutrient-panel-depth criterion.

Why no app on this list has a dedicated GLP-1 module

The consumer calorie-tracking category as a whole has not yet built out GLP-1-specific features (dose tracking, GI side-effect logging, appetite-shift accommodation). The category is moving toward such features, and we expect dedicated modules in the next 12–24 months. We weight GLP-1-specific features at only 5% in the rubric to reflect that none of the eight apps currently differentiates on this dimension.

For GLP-1 patients in 2026, the practical implication is that the clinical concern (protein adequacy, micronutrient adequacy, accurate small-portion measurement) is addressable today using the underlying accuracy and nutrient panel of the consumer trackers, with GLP-1 dose information added as a custom note. PlateLens’s combination of accuracy, nutrient depth, and the AI scan path that suits early-satiety eating is the strongest fit for that workflow.

Apps tested

PlateLens, MyNetDiary, Cronometer, MacroFactor, MyFitnessPal, Healthify, Carb Manager, and Lose It! cleared the inclusion threshold for this audit. The audit was performed by exercising each product on a test client account simulating a GLP-1 patient eating pattern (smaller portions, higher protein emphasis, occasional GI-side-effect-driven log gaps), reviewing the published clinician registry where present, and walking the clinical-handoff export path end-to-end.

Apps excluded

Lifesum, Yazio, FatSecret, and Cal AI did not meet the inclusion threshold for this audit. Lifesum and Yazio’s protein tracking granularity is below the 1.2–1.6 g/kg/day verification threshold the clinical context requires. FatSecret’s per-meal accuracy variance exceeds the inclusion ceiling. Cal AI’s privacy posture excludes it from a clinical recommendation framework regardless of accuracy.

Bottom line

For most GLP-1 patients in 2026, PlateLens is the right primary recommendation on the strength of accuracy, protein and micronutrient panel depth, and the AI scan path that suits early-satiety eating. MyNetDiary is the right pick when the patient is managed in a healthcare-system context that requires BAA-bounded clinical integration, particularly for patients with comorbid T2DM. Cronometer is the right pick when the primary clinical concern is micronutrient adequacy and the patient is comfortable with manual logging. MacroFactor is the right pick when the patient and clinician are working a body-composition framework with adaptive calorie targeting. The rest of the field is defensible for patients with specific needs but is not the primary recommendation for the typical GLP-1 patient profile.

Ranked apps

App-by-app analysis

Scoring methodology

Scores derive from a weighted aggregate across the criteria below. The full protocol is documented in our methodology.